End-of-Year Omnibus Spending Package and COVID Relief Bill
Analysis from PESA Vice President Government Affairs Tim Tarpley Late Monday night, Congress finalized discussions on the year-end $1.4 trillion government spending... Read More
PESA Racial Equality Working Groups Provide Progress Updates
PESA’s Racial Equality Task Force met on December 15 to hear progress reports from each of the working groups on specific action... Read More
Sen. Ted Cruz Discusses Paris Agreement, Climate Policy, Election
Culminating a series of Government Affairs townhalls, PESA hosted U.S. Sen. Ted Cruz (R-TX) on December 16 for a discussion of key policy... Read More
PESA President Talks Energy Transition, Future of Energy With Halliburton Labs Advisory Board
PESA President Leslie Beyer analyzed energy trends, changes in the energy landscape, and the factors driving energy transition during a panel discussion... Read More
States Begin COVID-19 Vaccine Distribution, Next Phases Remain Unclear
On Tuesday, the Food and Drug Administration (FDA) confirmed that Moderna’s vaccine is effective and safe for use. An independent committee will... Read More
Election Update: Climate Change Policies, Congressional Energy Bill
Analysis from PESA Vice President Government Affairs Tim Tarpley TRANSITION UPDATEThe Electoral College met across the country in their respective states and... Read More
Energy in Transition Podcast Features Scott Gale, Executive Director, Halliburton Labs
The Energy in Transition podcast, hosted by Council CEO Leslie Beyer, has released a new episode, which features a conversation with Scott... Read More
High-Performer Spotlight: Lauren Benson, HR Business Partner & Manager, Gardner Denver
Lauren Benson, HR Business Partner & Manager, Gardner Denver, joined the oil and gas industry at a high point in the business... Read More
Looking Back at 2020
PESA Members, As 2020 draws to a close, we’re grateful for your continued membership in PESA. Through a price war, a pandemic that crushed... Read More
COVID-19 Vaccine Distribution Plan in Critical OFS States
Following an international rush to develop a COVID-19 vaccination, the Food and Drug Administration (FDA) has confirmed the safety and efficacy of Pfizer’s coronavirus... Read More